Fri 07/22/2022 13:00 PM
Vita Health Group sale update from Reorg's
EMEA Middle Market team.
Relevant Documents:
FY’20 Accounts
FY’20 Accounts (Kingfisher Topco)
Direct lenders are monitoring the sale of U.K. healthcare provider Vita Health Group based on marketed EBITDA of £6 million to £8 million, sources told Reorg.
The auction is in its first round of bids and is attracting a number of private equity sponsors, sources noted. Deloitte is running the sale.
Vita provides both physical and mental...
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.